International Journal of Diabetes & its Complications
ISSN: 2573-8895 | DOI: 10.64030/2573-8895
Zaid W. Jabbar, Matthew Z Jabbar and Riyadh N Rehani
Obesity, defined by excessive and abnormal fat accumulation, remains a rapidly escalating global health crisis. It is a major contributor to numerous comorbidities, increased morbidity and mortality, and poses significant clinical and public health challenges. Furthermore, obesity and type 2 diabetes are closely interconnected through a complex interplay of metabolic, hormonal, and inflammatory pathways. Effectively addressing obesity is essential for both the prevention and management of type 2 diabetes. Given their strong association, weight control emerges as a critical strategy in reducing the global burden of diabetes. Managing obesity is complex due to its multifactorial nature, as well as a combination of significant biases toward the disease and lack of education. There are many approaches to dealing with obesity, such as lifestyle, pharmacotherapy, and surgery. This paper focuses on pharmacotherapy by introducing the G-SLIMTM algorithm and its potential role in providing a structured approach to pharmacotherapy for obesity management. It draws parallels to established treatment algorithms for other chronic conditions like diabetes, hyperlipidemia, and hypertension by introducing stepwise and layering medication selections. It explores the prevalence and challenges of obesity management and the economic impact of current pharmacological options. When a single medication is ineffective—due to inadequate weight loss, adverse effects, medical contraindications, or limited accessibility- this article outlines strategies for selecting an alternative therapy. An example of an effective medication is a GLP-1 receptor agonist, with additional therapies introduced based on the patient’s response and individual needs. It presents a stepwise, layered approach to medication initiation, targeting the various pathophysiological mechanisms involved in obesity. Additionally, certain medications may address both diabetes and weight management, which should be considered during treatment planning. In conclusion, the G-SLIMTM algorithm employs a structured, stepwise approach to pharmacotherapy for obesity and diabetes, emphasizing the strategic layering of medications to address multiple pathophysiological targets. This method mirrors evidence-based treatment paradigms used in other chronic diseases such as diabetes, hyperlipidemia, and hypertension, reinforcing the importance of combination therapy in achieving long-term management and improved clinical outcomes.